Tag: (CSE: IMH; OTC: IVITF; FRA: 8IS)

March 29, 2017

Invictus MD Appoints Interim Chief Financial Officer

INVICTUS MD STRATEGIES (CSE: IMH; OTC: IVITF; FRA: 8IS) Invictus MD is pleased to announce that Herrick Lau has been appointed...
March 23, 2017

Invictus MD's AB Laboratories Provides Cultivation Update under ACMPR

INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) Invictus MD announces that AB Laboratories...
March 14, 2017

Invictus MD Announces Completion of its Commitment to Acquire 33.33% of Licensed Producer AB Laboratories Inc.

VANCOUVER, March 14, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS)...
March 9, 2017

Invictus MD's Chairman and CEO Granted Stock Options

VANCOUVER, BC / TheNewswire / March 9, 2017 - Invictus MD Strategies Corp. (CSE: IMH; OTC: IVITF; FRA: 8IS).
March 7, 2017

Invictus MD's Future Harvest Achieves Increase In Gross Margin Resulting From Increased Fertilizer Sales In The Cannabis-Centric Space

VANCOUVER, March 7, 2017 /PRNewswire/ - Invictus MD Strategies Corp. (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to report...
March 3, 2017

Invictus MD Closes $16,218,065 Bought Deal Private Placement

Invictus MD Strategies Corp (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has closed its previously...
March 2, 2017

Invictus MD Closes $16,218,065 Bought Deal Private Placement

Vancouver, BC, March 2, 2017 - Invictus MD Strategies Corp. (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce...